| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Lion Biotechnologies | 5,604,015 | 67,865,000 | 99.40% | ||
| 2 | ONCOTHYREON INC COM N/C EFF 6/ | 250,000 | 407,000 | 0.60% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-15-021061, filed 2015.05.20).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
